Eric Benevich

Eric Benevich

DirectoratNeurocrine Biosciences· In proxies 2022–2025

Pay in FY2022Neurocrine Biosciences stock +40.2% the same year

Eric Benevich was paid $2.5M in FY2022 (Dec). Neurocrine Biosciences stock rose 40.2% that year.

Pay$100 in the stock at the end of FY21 → $140
Pay is from the Summary Compensation Table of each Neurocrine Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. aTYR PharmaPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. Neurocrine BiosciencesPublic company · 4 yr
    • Chief Commercial Officer2022 – Present · 4 yrStock in role +72%

Roles come from the proxy statements of each company.

Boards1

  • aTYR PharmaDirector · 1 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?